All > Irritable Bowel Syndrome > Ibs

a low FODMAP diet for 4 weeks for Irritable Bowel Syndrome

University of Michigan, Ann Arbor, MI
Irritable Bowel Syndromea low FODMAP diet for 4 weeks - Other
Eligibility
18 - 65
All Sexes

Study Summary

This trial is testing whether dietary changes can improve symptoms of Irritable Bowel Syndrome.

Eligible Conditions
  • Irritable Bowel Syndrome

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Low FODMAP diet/PEG 3350
2
Tenpanor 50 mg BID
2
apraglutide

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 4 weeks

4 weeks
Changes in epithelial permeability
Changes in stool microbiome
Lactulose Mannitol excretion

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Low FODMAP diet/PEG 3350
3
Tenpanor 50 mg BID
3
apraglutide

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Study patients with IBS-D
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: a low FODMAP diet for 4 weeks · No Placebo Group · N/A

Study patients with IBS-D
Other
Experimental Group · 1 Intervention: a low FODMAP diet for 4 weeks · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks

Who is running the clinical trial?

University of MichiganLead Sponsor
1,673 Previous Clinical Trials
6,422,221 Total Patients Enrolled
11 Trials studying Irritable Bowel Syndrome
852 Patients Enrolled for Irritable Bowel Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,213 Previous Clinical Trials
4,193,659 Total Patients Enrolled
23 Trials studying Irritable Bowel Syndrome
3,532 Patients Enrolled for Irritable Bowel Syndrome
Prashant SinghPrincipal Investigator - University of Michigan
University of Michigan C.S. Mott Children's Hospital, University of Michigan Health System, University of Michigan Hospital, Von Voigtlander Women's Hospital

Eligibility Criteria

Age 18 - 65 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Does this experiment necessitate a minimum age requirement of eighteen years?

"The trial necessitates that patients between the age of 18 and 65 join, but there are alternative studies for those outside this range--405 trials for minors and 1045 for seniors." - Anonymous Online Contributor

Unverified Answer

Are additional participants still being taken into this research program?

"Affirmative. Clinicaltrials.gov provides evidence that this study, which was initially made public on August 3rd 2020, is currently enrolling volunteers. Approximately 50 participants are needed from a single location." - Anonymous Online Contributor

Unverified Answer

Who meets the criteria for enrollment in this clinical study?

"In order to be eligible for the trial, individuals should demonstrate symptoms of irritable bowel syndrome and fall into the age range of 18 to 65. As of now, there are about 50 slots open for participation." - Anonymous Online Contributor

Unverified Answer

How many participants have been recruited to participate in this trial?

"Affirmative. According to the clinicaltrials.gov website, this research is actively enrolling participants - having been first posted on August 3rd 2020 and recently updated on May 27th 2022. The study necessitates 50 individuals from 1 medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top